title: Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid.
authors.forename: Hong-Sheng
authors.initials: HS
authors.lastname: Zhou
authors.forename: Min
authors.initials: M
authors.lastname: Dai
authors.forename: Yongqiang
authors.initials: Y
authors.lastname: Wei
authors.forename: Qiang
authors.initials: Q
authors.lastname: Wang
authors.forename: Na
authors.initials: N
authors.lastname: Xu
authors.forename: Changxin
authors.initials: C
authors.lastname: Yin
authors.forename: Fanyi
authors.initials: F
authors.lastname: Meng
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D001752:Blast Crisis; D001921:Brain / Q000473:pathology; D002490:Central Nervous System / Q000473:pathology*; D000069439:Dasatinib; D016313:Genes, abl; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D009154:Mutation; D009364:Neoplasm Recurrence, Local; D047428:Protein Kinase Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D011743:Pyrimidines / Q000493:pharmacokinetics / Q000627:therapeutic use; D012074:Remission Induction; D013844:Thiazoles / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib